TY - JOUR
T1 - Maternal Health Service Uptake Is Associated with a Higher Skin-to-Skin Care Practice in Ethiopia
T2 - Result from a National Survey
AU - Nigatu, Dabere
AU - Abeje, Gedefaw
AU - Mekonnen, Alemayehu G.
AU - Azage, Muluken
AU - Bogale, Daniel
N1 - Publisher Copyright:
© 2020 Dabere Nigatu et al.
PY - 2020
Y1 - 2020
N2 - Background. Though skin-to-skin care (SSC) is becoming an important newborn care package at both facility and community levels in Ethiopia, there is a lack of evidence to monitor the progress at each level. Therefore, this study is aimed at quantifying the proportion of SSC at both national and regional levels and identifying factors that affect SSC uptake in Ethiopia. Method. We used the 2016 Ethiopia Demographic and Health Survey data. The survey employed a multistage cluster sampling method. We included 7,488 live births in the analysis. The factors influencing SSC practice were identified using a multivariable logistic regression model. We reported adjusted odds ratios (AORs) with 95% confidence intervals (CIs). Results. In Ethiopia, 24.3% of mothers practiced SSC for their newborns (95% CI=23.3, 25.2). The highest proportion was in Addis Ababa (63%), and the lowest was in the Somali region (14.5%). Attending 1-4 antenatal care (AOR=1.51, 95%CI=1.08,2.12, giving birth at health facility (AOR=4.51, 95%CI=2.16,9.44, and having female births (AOR=1.24, 95%CI=1.01,1.54) were associated with more odds of practicing SSC. However, giving birth by the cesarean section had resulted in lower odds of practicing SSC (AOR=0.37, 95%CI=0.22,0.63). Regions with reduced odds of SSC practice include Amhara (AOR=0.57, 95%CI=0.40,0.82), Somali (AOR=0.51, 95%CI=0.31,0.83), and Southern Nations, Nationalities, and People (AOR=0.64, 95%CI=0.43,0.94). Conclusions. The SSC practice was low in Ethiopia with a high level of variation between regions. In Ethiopia, maternal health service uptake affects the SSC of the newborns. Well-tailored community-level interventions are needed to increase skin-to-skin care practice among home delivery mothers.
AB - Background. Though skin-to-skin care (SSC) is becoming an important newborn care package at both facility and community levels in Ethiopia, there is a lack of evidence to monitor the progress at each level. Therefore, this study is aimed at quantifying the proportion of SSC at both national and regional levels and identifying factors that affect SSC uptake in Ethiopia. Method. We used the 2016 Ethiopia Demographic and Health Survey data. The survey employed a multistage cluster sampling method. We included 7,488 live births in the analysis. The factors influencing SSC practice were identified using a multivariable logistic regression model. We reported adjusted odds ratios (AORs) with 95% confidence intervals (CIs). Results. In Ethiopia, 24.3% of mothers practiced SSC for their newborns (95% CI=23.3, 25.2). The highest proportion was in Addis Ababa (63%), and the lowest was in the Somali region (14.5%). Attending 1-4 antenatal care (AOR=1.51, 95%CI=1.08,2.12, giving birth at health facility (AOR=4.51, 95%CI=2.16,9.44, and having female births (AOR=1.24, 95%CI=1.01,1.54) were associated with more odds of practicing SSC. However, giving birth by the cesarean section had resulted in lower odds of practicing SSC (AOR=0.37, 95%CI=0.22,0.63). Regions with reduced odds of SSC practice include Amhara (AOR=0.57, 95%CI=0.40,0.82), Somali (AOR=0.51, 95%CI=0.31,0.83), and Southern Nations, Nationalities, and People (AOR=0.64, 95%CI=0.43,0.94). Conclusions. The SSC practice was low in Ethiopia with a high level of variation between regions. In Ethiopia, maternal health service uptake affects the SSC of the newborns. Well-tailored community-level interventions are needed to increase skin-to-skin care practice among home delivery mothers.
UR - http://www.scopus.com/inward/record.url?scp=85098566086&partnerID=8YFLogxK
U2 - 10.1155/2020/8841349
DO - 10.1155/2020/8841349
M3 - Article
C2 - 33415162
AN - SCOPUS:85098566086
SN - 2314-6133
VL - 2020
JO - BioMed Research International
JF - BioMed Research International
M1 - 8841349
ER -